DIM — Sartorius Stedim Biotech SA Share News
0.000.00%
- €21.72bn
- €23.90bn
- €2.97bn
Brief: Sartorius Sharpens Strategy With Biopharma Focus, Sets New Midterm Growth Targets
Brief: Sartorius Stedim Biotech Eyes 60-85 Bps Underlying EBITDA Margin Increase Per Year From 2027
Europe Research Roundup: Airbus, Mercedes-Benz Group, Safestore Holdings
Brief: Sartorius Proposes Dividend Of 0.74 Euros Per Preference Share
Europe Research Roundup: Berkeley Group, Next 15 Group, Westwing Group
Brief: Sartorius Forecasts 2026 Sales Revenue Growth In Constant Currencies To Be Between Around 5 And 9 Percent
Brief: Sartorius Stedim Biotech FY 2025 Sales Revenue EUR 2.97 Bln
Top of the Street: Societe Generale, BMW, Porsche, Aviva
RBC cuts Sartorius on limited near-term upside potential
Europe Research Roundup: BNP Paribas, Swedbank, Volkswagen
BNP picks medtech favourites, sees re-rating in H2 2026
Europe Research Roundup: Auto1 Group, Roche Holding, Sanofi
Europe Research Roundup: Aryzta, Secunet Security Networks, Whitbread
Europe Research Roundup: Aurubis, Nestle, Playtech
Sartorius at 5-month highs after FY guidance hike, Q3 beat
Brief: Sartorius Sharpens Guidance After 9M Sales Revenue Growth
Brief: Sartorius Stedim Biotech Unaudited Results For First Nine Months Of 2025
Refile: BUZZ-'Overall a relief': TrumpRx price cuts deals boost European pharma stocks
Europe Research Roundup: Accor, Equinor, Siemens